Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 32 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

SSP is a flexible and predictive neighborhood‐level measure of health disparities compared to indices like the Gini coefficient. Result Among 2.5–2.7 million beneficiaries annually, dementia prevalence declined from 9.6% in 2015 to 8.7% in 2018, despite growth in the beneficiary population. Greater neighborhood privilege (higher ICE scores) was consistently associated with lower dementia prevalence (β ∼ ‐0.04 to ‐0.06; p < 0.01). PIM simulations suggested that reducing deprivation in ICE domains could lower dementia prevalence by up to 1.9%. Conclusion Neighborhood‐level deprivation and racial segregation are associated with increased ADRD prevalence, independent of individual characteristics.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Magid, H. S. A., & Xu, M. (2025). Neighborhood Spatial Social Polarization and Dementia Disparities Among U.S. Medicare Beneficiaries. Alzheimer's & Dementia. https://doi.org/10.1002/alz70861_108433

Vancouver

Magid HSA, Xu M. Neighborhood Spatial Social Polarization and Dementia Disparities Among U.S. Medicare Beneficiaries. Alzheimer's & Dementia. 2025. doi:10.1002/alz70861_108433.

BibTeX

@article{magid2025-ded959fb,
  author  = {Magid, Hoda S Abdel and Xu, Mengya},
  title   = {{Neighborhood Spatial Social Polarization and Dementia Disparities Among U.S. Medicare Beneficiaries}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70861_108433},
  url     = {https://doi.org/10.1002/alz70861_108433}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that Medicare beneficiaries living in more deprived or racially segregated neighborhoods had higher dementia prevalence, independent of individual characteristics. It does not test a treatment or cure, but it suggests that reducing neighborhood deprivation could be explored as a way to lower dementia prevalence.

Study details

How this study scored 32/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 2 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. 31 of the 96 points it could be judged on, which is 32 of 100. Total 32 of 100.31 of the 96 points we could judge = 32 of 100

Published in a leading specialty journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 31 of the 96 points we could judge it on, which is 32 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Alzheimer's & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Mengya Xu holds only 3 work(s), too few to judge a track record — left out of this score
Institution's track record 2 / 3 University of Southern California: institution h-index 1,521 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 31 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 31 of the 96 points we could judge it on is 32 out of 100.
Total 32 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Related studies in Risk factors

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Risk factors

See all studies in Risk factors →